These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35977127)

  • 1. Intravenous Iron vs. Oral Iron in Iron Deficiency Anemia.
    Mounsey A; Peacock E; Magnusson L
    Am Fam Physician; 2022 Aug; 106(2):191-192. PubMed ID: 35977127
    [No Abstract]   [Full Text] [Related]  

  • 2. Iron supplementation in a case of severe iron deficiency anaemia.
    Füllenbach C; Triphaus C; Glaser P; Ziebart A; Zacharowski K; Meybohm P; Choorapoikayil S
    Br J Anaesth; 2018 Aug; 121(2):502-504. PubMed ID: 30032895
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial.
    Vanobberghen F; Lweno O; Kuemmerle A; Mwebi KD; Asilia P; Issa A; Simon B; Mswata S; Schmidlin S; Glass TR; Abdulla S; Daubenberger C; Tanner M; Meyer-Monard S
    Lancet Glob Health; 2021 Feb; 9(2):e189-e198. PubMed ID: 33245866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative anaemia and iron deficiency.
    Menon A; Warnakulasuriya SR
    Br J Hosp Med (Lond); 2022 Aug; 83(8):1-3. PubMed ID: 36066297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of a protocol for management of antepartum iron deficiency anemia: a prospective cohort study.
    Hamm RF; Wang EY; Levine LD; Speranza RJ; Srinivas SK
    Am J Obstet Gynecol MFM; 2022 Mar; 4(2):100533. PubMed ID: 34808403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of high-dose intravenous iron in middle-aged to elderly iron-deficient patients.
    Khiatani D; Tay HS; Cushway TR
    Med J Malaysia; 2022 Sep; 77(5):628-630. PubMed ID: 36169078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron deficiency anemia treatment response to oral iron therapy: a pooled analysis of five randomized controlled trials.
    Okam MM; Koch TA; Tran MH
    Haematologica; 2016 Jan; 101(1):e6-7. PubMed ID: 26518747
    [No Abstract]   [Full Text] [Related]  

  • 8. Parenteral iron therapy.
    Kaplinsky C
    Isr Med Assoc J; 2008 May; 10(5):372-3. PubMed ID: 18605363
    [No Abstract]   [Full Text] [Related]  

  • 9. [Iron deficiency anemia and newly available iron preparations].
    Ikuta K
    Rinsho Ketsueki; 2022; 63(9):1026-1034. PubMed ID: 36198525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in intravenous iron treatment.
    Marx JJ
    Arzneimittelforschung; 2010; 60(6a):341-4. PubMed ID: 20648925
    [No Abstract]   [Full Text] [Related]  

  • 11. Comment on: Intravenous ferric carboxymaltose for iron deficiency anemia or iron deficiency without anemia after poor response to oral iron treatment: Benefits and risks in a cohort of 144 children and adolescents.
    Schmugge M; Mattiello V; Hengartner H; von der Weid N; Renella R;
    Pediatr Blood Cancer; 2021 Mar; 68(3):e28726. PubMed ID: 32969156
    [No Abstract]   [Full Text] [Related]  

  • 12. Iron deficiency testing and treatment in heart failure: the eyes are useless when the mind is blind.
    Miñana G; Bayés-Genís A; Núñez J
    Eur J Heart Fail; 2021 Nov; 23(11):1855-1857. PubMed ID: 34655260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant/refractory to iron sulfate: a multicentric randomized study.
    Giordano G; Napolitano M; Di Battista V; Lucchesi A
    Ann Hematol; 2021 Sep; 100(9):2173-2179. PubMed ID: 33263170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial.
    Macdougall IC; Bock AH; Carrera F; Eckardt KU; Gaillard C; Van Wyck D; Meier Y; Larroque S; Roger SD;
    BMC Nephrol; 2017 Jan; 18(1):24. PubMed ID: 28095881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Hemoglobin Response with Ferric Carboxymaltose in Patients with Gastrointestinal-Related Iron-Deficiency Anemia Versus Oral Iron.
    Lichtenstein GR; Onken JE
    Dig Dis Sci; 2018 Nov; 63(11):3009-3019. PubMed ID: 30056562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous iron sucrose--an effective and attractive modality for perioperative anaemia management.
    Froessler B; Papendorf D
    Anaesth Intensive Care; 2010 Sep; 38(5):960-2. PubMed ID: 20865896
    [No Abstract]   [Full Text] [Related]  

  • 17. A systematic literature review and indirect comparison of iron isomaltoside and ferric carboxymaltose in iron deficiency anemia after failure or intolerance of oral iron treatment.
    Pollock RF; Muduma G
    Expert Rev Hematol; 2019 Feb; 12(2):129-136. PubMed ID: 30689458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A synchronized approach between emergency department and anemia clinic to intravenous iron treatment for very severe (Hb <7.0 g/dL) and extreme (<5.0 g/dL) iron-deficiency anemia: short-, medium- and long-term efficacy and safety analysis.
    Beverina I; Ranzini M
    Blood Transfus; 2023 May; 21(3):235-239. PubMed ID: 36795347
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous iron for the treatment of iron deficiency anemia in China: a patient-level simulation model and cost-utility analysis comparing ferric derisomaltose with iron sucrose.
    Hu S; Liu L; Pollock RF; Pöhlmann J; Wu D; Zhang Y
    J Med Econ; 2022; 25(1):561-570. PubMed ID: 35403540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferric Maltol: A New Oral Iron Formulation for the Treatment of Iron Deficiency in Adults.
    Khoury A; Pagan KA; Farland MZ
    Ann Pharmacother; 2021 Feb; 55(2):222-229. PubMed ID: 32633548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.